FDPS · Drug policy priorities
Drug policy priorities
Where the Foundation for Drug Policy Solutions stands, what it is asking Congress and the agencies to do, and how to help. Every page is sourced, updated and written for the people who make the decisions.
The issues
Four drug policy priorities for 2026
Each page lays out where the law stands, what the evidence says, what FDPS is asking for and how to act. They are updated as the policy moves.
Psychedelics · FDA docket open to October 5, 2026Psychedelics: science firstWashington is fast-tracking hallucinogens before the evidence is in. The record, the harms and the standard FDPS is defending.
Kratom · 7-OH scheduled July 2026Ban kratom. The whole plant.The DEA banned half of the molecule. The leaf is still sold at gas stations. The case for finishing the job, with every claim sourced.
Prevention · H.R. 6902 and S. 1611A national youth drug prevention campaignThe bill FDPS endorsed would fund the first national youth prevention media campaign in more than a decade. What it does and who backs it.
The plan · The Hyannis ConsensusThe Blueprint for Effective Drug PolicySixteen recommendations from nearly 100 experts across prevention, treatment, recovery, supply and criminal justice.
Go deeper
Briefings, research and model laws
BriefingKratom: facts, harms and the case for a banThe science, the state-by-state map and advice for parents.
Drug FactsPlain-language briefings by substanceFentanyl, kratom and 7-OH, psychedelics, marijuana and more.
Policy researchWhite papers, testimony and op-edsIbogaine, harm reduction, safe supply and supervised consumption.
Model lawsModel state drug lawsReady-to-file legislation from NAMSDL, the FDPS model-law division.
TrainingsBring FDPS to your communityData-driven drug policy trainings for coalitions, schools and lawmakers.
NewsStatements and pressFDPS responses to the latest federal and state developments.
Drug FactsPlain-language briefings by substanceFentanyl, kratom and 7-OH, psychedelics, marijuana and more.
Policy researchWhite papers, testimony and op-edsIbogaine, harm reduction, safe supply and supervised consumption.
Model lawsModel state drug lawsReady-to-file legislation from NAMSDL, the FDPS model-law division.
TrainingsBring FDPS to your communityData-driven drug policy trainings for coalitions, schools and lawmakers.
NewsStatements and pressFDPS responses to the latest federal and state developments.
Good drug policy needs people who show up.
Add your name, write your representatives and bring the evidence to the people who make the decisions.
